HELP Helus Pharma Inc.

$HELP $HELP H.C. Wainwright reiterated BUY with a $70 price target on Oct 8. Nearly 487% upside from $11.92. Bullish on HLP003 Phase 3 potential, backed by FDA Breakthrough Therapy designation. Major trial results expected in November.

Bought an extra 1,000 shares of $HELP and $CMPS near market lows today. Up to 33,500 shares of CMPS and 22,600 shares of HELP, which is more than I wanted but this dip is dipping.

$HELP just a wave of founder insider buys this week. Eric So and Paul Glavine buying millions of dollars worth in the open market. Any other founders buying like this in the sector? I didn’t think so. All that fraud talk over the years was just nonsense. They never sold a share in that time, were diluted like the rest of us. Now they are buying millions. Something big is coming…

$HELP bottom is in, as I mentioned yesterday. We have a huge opportunity in the next 3 months as a company and for the whole sector to really make serious money. Good luck to everyone this quarter will make or break a lot of investors. For those who have high conviction I hope you accumulated during these lows

$HELP Insiders keep on buying. You're selling? You're not smart. Company value Above 2.5B. Do the math.

$HELP MAHA summit Just started.Psychedelic topic starting at 9.40 am $HELP CEO/ $CMPS CEO/ $DFTX CEO will speak there.

$HELP I'm still down from my average $13 but this is why I load the boat. When a good stock moves, it moves and KEEPS On Moving. I'm waiting for Phase 3 results for my $30 per share then hanging on for more. Do your own due diligence. No Financial Advice. IMO.

$HELP $CMPS its going to be hysterically HILARIOUS when shorts have to cover after HELP Phase 3 approval and CMPS FDA approval of the only breakthrough therapy of its kind 🤣🤣🤣🤣😭😂😂😂

$HELP the dip this week has been due to bond yields. Nothing to do with the stock or the broader psychedelics sector at all. They should pull back Monday with an announcement from the White House on an oil flow again deal they are considering with Iran. Halstead buying a 100k shares at 13.47 tells you all you need to know. MAHA Summit next week and then we are in the data drop window with great odds (60-70 percent) for a 2-4x ($25-$50 a share). Today is the day to load.

$HELP Thought I was done buying but in for 500 more shares - have 20,600 shares total now.

$HELP I get paid next Thursday. Gonna add another 100 share are this level for sure. Huge upside opportunity 🚀

$HELP The Math: The HPL003 by capturing the adjunctive market instead of just TRD, the accessible patient pool instantly expands by a factor of 2x to 3x larger. IF, Phase 3 comes in Strong there's a potential very big market. IMO.

$HELP $CMPS now is the time to buy it might get lower too - but we know what we own. In terms of risk, HELP is literally the same compound (clinically speaking) following the same phase 2 design - BOTH are going to be great. I’d rather people who don’t know what they’re holding sell - bye - go invest in space x or the AI bubble, lmao BULLISH on $HELP and $CMPS bc I know what they mean clinically and the world needs both of them desperately. There are NO other treatments like them PERIOD end of story.

$HELP MASSIVE that the study is structured as such that you can continue to stay on your current antidepressants and don’t have to “wash out” which is a major barrier for psych patients for companies like CMPS and how their study is structured!!

$HELP Maybe next week we can have some follow through and get in the $15 range. The Phase 3 results can come at anytime although most think in the first two weeks of November (and that sounds right to me) as they need time to analyze the data and double check it. I'm hoping results are great and they are trying to shop the company to find a buyer among Big Pharma for a buyout. Then I would not have to work so hard researching this stock 24/7, and maybe take a vacation as I need one. IMO.

$HELP CEO dropping his own personal cash in this, this deep in the game is incredibly bullish.

$HELP four executives bought ~$8.4M of stock on the open market in the last month: co-founder/exec chair Eric So $3.6M (Sept 1–8), chief growth officer Paul Glavine $3.5M (Aug 31–Sept 8), CEO Michael Halstead $1.35M (Sept 21, more than doubling his stake), and CFO Greg Cavers $39K (Sept 29). None of it was under 10b5-1 plans. That's the C-suite putting real money in ahead of the Q4 APPROACH Phase 3 topline readout. Interesting signal of management confidence into a binary event. We shall see if it proves to be warranted?

$HELP they rebranded because they're now a pre -commercial company. Phase 3 is good. Golden here.

$HELP based on this, to be sure, I thought I'd dig into insider open-market purchases in CNS in the 90 days before each of the readouts, then compare with what happened. It's quite striking how rare insider buying before a readout is at all. However, 29 psychiatric and CNS readouts. 26 have US insider filings. In 22 of the 26, no insider bought a single share in the 90 days before. That includes most of the big winners: Definium’s Emerge, AtaiBeckley, Acadia, Intra-Cellular and Compass’s COMP006. Only four had insider buying: Karuna EMERGENT-2, 2022 - clean beat +72% Day 1 Axsome GEMINI, 2019, Clean Beat +71% Sage SKYLARK, 2022 Positive, 13% at 30 Days Relmada RELIANCE II, 2024 - stopped for futility, -46% at 30 days All in all to say, it's interesting that this kind of buying is unusual + it has been usually followed by success. But in the last one, CEO and 3 directors all bought. Management-wide conviction has failed before (20%). 1/?

$HELP when u consider that they now have topline in hand and that secondary data is in hand probably now or no later than next Wed- the timing of the Oct 21 webcast gets much more intriguing. Why schedule a call and say it’s a bit too soon to talk about data you already have 🤣 off to the races brothers. Remember mgmt bought 8 mil worth a few weeks at higher market prices, this is a rare defensive move to put out a PR like this during times of manipulation, there may be buyout negotiation pressure at this very moment